Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Research and Development Contracts (N01)
Project #
N01MH041003-003
Application #
7191232
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
2005
Total Cost
Indirect Cost

  Institution

Name
University of California Los Angeles
Department
Type
DUNS #
City
State
Country
Zip Code

  Publications

Jarskog, L Fredrik; Dong, Zhengchao; Kangarlu, Alayar et al. (2013) Effects of davunetide on N-acetylaspartate and choline in dorsolateral prefrontal cortex in patients with schizophrenia. Neuropsychopharmacology 38:1245-52
Gonzalez, Jodi M; Rubin, Maureen; Fredrick, Megan M et al. (2013) A qualitative assessment of cross-cultural adaptation of intermediate measures for schizophrenia in multisite international studies. Psychiatry Res 206:166-72
Javitt, Daniel C; Buchanan, Robert W; Keefe, Richard S E et al. (2012) Effect of the neuroprotective peptide davunetide (AL-108) on cognition and functional capacity in schizophrenia. Schizophr Res 136:25-31
Buchanan, Robert W; Keefe, Richard S E; Lieberman, Jeffrey A et al. (2011) A randomized clinical trial of MK-0777 for the treatment of cognitive impairments in people with schizophrenia. Biol Psychiatry 69:442-9